In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B
about
Treatment and prophylaxis of invasive candidiasisIdentification of Aspergillus fumigatus and related species by nested PCR targeting ribosomal DNA internal transcribed spacer regionsNew investigational antifungal agents for treating invasive fungal infections.Antifungal pharmacodynamics: review of the literature and clinical applications.Investigational antifungal agents.Elucidating drug resistance in human fungal pathogens.Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.New and emerging antifungal agents: impact on respiratory infections.Pharmacokinetics of antifungal agents in children.Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazoleIn vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates.Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.New and investigational triazole agents for the treatment of invasive fungal infections.New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature.Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.Pharmacological agents in development for invasive aspergillosis.In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.Proteomic and transcriptomic analysis of Aspergillus fumigatus on exposure to amphotericin B.Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.New agents for the treatment of systemic fungal infections--current status.Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits.Azole Resistance in Aspergillus fumigatus: Mechanisms, Route of Resistance Selection, and Clinical ImplicationsA phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis
P2860
Q27001567-B87E16B1-16F9-4DC1-B788-2FB40E724D75Q33972636-3A59E7CE-BD71-4D94-AA35-09BDBA6CC895Q34075014-F2BF0BF6-BCFC-4B05-8325-B2431C500838Q34083129-E9290FEC-9E52-4171-ADE9-9544F743C28FQ34335243-51552787-FB63-429C-807D-70A52C7E4A9DQ34419351-2268B1D3-58F5-4B25-850F-B6DBD0791916Q35072285-EF893DB7-C9B6-4F14-8137-5F08AD3EFE4AQ35627629-EE610B0B-4475-4486-9957-9751138D8C22Q36163345-A0B7C84B-BAF1-47A5-9389-A096D0B7F393Q36491819-D9E97831-6EE5-412F-A096-3EF984955654Q36521993-B7B709D7-6BEE-4B41-8EF6-526C7B7D1D79Q36669593-7E6D4AEB-749C-4064-AC1F-770D7AD39399Q37119029-04AF01AC-E67B-4579-B0F6-EE74977FCA90Q37364295-147C3FE9-5E60-4F5B-B8BA-C811F87B0322Q37608276-2EFE01ED-9FFC-4234-8314-7FC874387A68Q37864427-ACA097EF-203A-4026-B9A2-29F600188A01Q38285488-DD0EDFEC-B76D-4458-BFDF-CA41159D594FQ40409386-F438669D-796F-417F-83AE-2AB0F77897ADQ40668115-F1A2648C-9BC8-4D17-AFD6-6991A99E76FCQ41389247-A22C397E-9F02-46DF-978F-D4612EDD5418Q44066015-B29D86A1-403F-4185-87D3-C67F5FF3741BQ46576615-66C19FB0-23FB-4588-95CD-70410E6617C8Q46711208-CA81BBC5-6F95-4A88-A6CD-531EFE213C8BQ56993256-8801D955-1AE2-4190-B347-12597B809B62Q58404248-82D42EE7-3B48-4ACE-B5E2-106C903B855F
P2860
In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
In vitro activity of the new t ...... traconazole and amphotericin B
@ast
In vitro activity of the new t ...... traconazole and amphotericin B
@en
In vitro activity of the new t ...... traconazole and amphotericin B
@nl
type
label
In vitro activity of the new t ...... traconazole and amphotericin B
@ast
In vitro activity of the new t ...... traconazole and amphotericin B
@en
In vitro activity of the new t ...... traconazole and amphotericin B
@nl
prefLabel
In vitro activity of the new t ...... traconazole and amphotericin B
@ast
In vitro activity of the new t ...... traconazole and amphotericin B
@en
In vitro activity of the new t ...... traconazole and amphotericin B
@nl
P2860
P1476
In vitro activity of the new t ...... traconazole and amphotericin B
@en
P2093
P2860
P304
P356
10.1128/AAC.44.2.441-443.2000
P407
P577
2000-02-01T00:00:00Z